Patent classifications
C07K14/78
PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION
The present application provides methods and processes for making and using a fibronectin composition, as well as methods for treating ocular conditions and/or disorders with the cellular fibronectin composition described herein.
Method for evaluating multiple different genes of interest
It is an object of the present invention to provide, for instance, a method for evaluating a function, such as transforming potential, of multiple different genes of interest, and a method capable of evaluating drug sensitivity of a subject having each gene of interest. The present invention relates to, for instance, a method for evaluating multiple different genes of interest, comprising the steps of: integrating, into host cell genomic DNA, polynucleotides each comprising a tag sequence and a gene of interest or a fragment thereof linked to the tag sequence; mixing a plurality of different host cells having the different polynucleotides integrated therein; culturing the mixed host cells; extracting the genomic DNA from the cultured host cells; quantifying each of the polynucleotides in the extracted genomic DNA based on the tag sequence; and determining a relative cell count of each of the host cells having the respective polynucleotides after the culturing, based on the quantified values for the polynucleotides.
Methods and compositions for targeting tissue lesions
Provided are methods and compositions to target delivery of cells to a tissue lesion, thereby treating the lesion. For example, biotinylated antibodies with affinity to a lesion epitope are administered at the lesion. Reparative cells including avidin and biotin are then administered at the lesion. The reparative cells are targeted to the lesion via avidin-biotin bridges to the antibodies, with additional cells recruited to the lesion via cell-to-cell avidin-biotin bridges. In certain examples, antibody-reparative cell complexes are formed by mixing the biotinylated antibodies with the reparative cells including avidin and biotin. The complexes are then administered at the lesion. In other examples, multivalent antibodies are used to target reparative cells to the lesion, such as by binding an epitope at the lesion and an epitope present on the reparative cell. In other examples, the antibodies are chemically linked to a reparative cell or to a nanosome containing a therapeutic agent.
Methods and compositions for targeting tissue lesions
Provided are methods and compositions to target delivery of cells to a tissue lesion, thereby treating the lesion. For example, biotinylated antibodies with affinity to a lesion epitope are administered at the lesion. Reparative cells including avidin and biotin are then administered at the lesion. The reparative cells are targeted to the lesion via avidin-biotin bridges to the antibodies, with additional cells recruited to the lesion via cell-to-cell avidin-biotin bridges. In certain examples, antibody-reparative cell complexes are formed by mixing the biotinylated antibodies with the reparative cells including avidin and biotin. The complexes are then administered at the lesion. In other examples, multivalent antibodies are used to target reparative cells to the lesion, such as by binding an epitope at the lesion and an epitope present on the reparative cell. In other examples, the antibodies are chemically linked to a reparative cell or to a nanosome containing a therapeutic agent.
Glypican-3-binding fibronectin based scaffold molecules
Provided herein are polypeptides which include tenth fibronectin type III domains (.sup.10Fn3) that bind to glypican-3. Also provided are fusion molecules comprising a .sup.10Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3 .sup.10Fn3 drug conjugates are also provided.
Glypican-3-binding fibronectin based scaffold molecules
Provided herein are polypeptides which include tenth fibronectin type III domains (.sup.10Fn3) that bind to glypican-3. Also provided are fusion molecules comprising a .sup.10Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3 .sup.10Fn3 drug conjugates are also provided.
Pearl culture material, nucleus insertion method, and pearl culture material composition
There are provided a pearl culture material containing at least one selected from the group consisting of a pearl nucleus and a mantle, and the at least one selected from the group consisting of a pearl nucleus and a mantle contains a protein having 10 EU/g or less of an endotoxin amount, a nucleus insertion method, and a pearl culture material composition.
Pearl culture material, nucleus insertion method, and pearl culture material composition
There are provided a pearl culture material containing at least one selected from the group consisting of a pearl nucleus and a mantle, and the at least one selected from the group consisting of a pearl nucleus and a mantle contains a protein having 10 EU/g or less of an endotoxin amount, a nucleus insertion method, and a pearl culture material composition.
GREEN AND BROAD-SPECTRUM PROTEIN CROSS-LINKING METHOD
The present invention belongs to the technical field of medical biological materials, in particular to a green and broad-spectrum protein cross-linking method. In the method, a mixed solution containing protein and silver ions is irradiated by a visible light source with a compound wavelength to obtain cross-linked protein materials with uniform morphology. Compared with the traditional protein cross-linking method, the preparation method does not involve toxic chemical reagents and is environmentally friendly; the method can cross-link a variety of proteins in a broad spectrum; the preparation method can ensure the original activity of protein to the greatest extent; the preparation method also has the advantages of simple steps and easy operation; the cross-linked protein prepared by the method has good biological activity and antibacterial properties, and has great application prospect.
GREEN AND BROAD-SPECTRUM PROTEIN CROSS-LINKING METHOD
The present invention belongs to the technical field of medical biological materials, in particular to a green and broad-spectrum protein cross-linking method. In the method, a mixed solution containing protein and silver ions is irradiated by a visible light source with a compound wavelength to obtain cross-linked protein materials with uniform morphology. Compared with the traditional protein cross-linking method, the preparation method does not involve toxic chemical reagents and is environmentally friendly; the method can cross-link a variety of proteins in a broad spectrum; the preparation method can ensure the original activity of protein to the greatest extent; the preparation method also has the advantages of simple steps and easy operation; the cross-linked protein prepared by the method has good biological activity and antibacterial properties, and has great application prospect.